Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Cruz Aponte, Maytee ^a   McKiernan, Erin C ^a,c   Herrera Valdez, Marco A ^a,b,c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PUERTO RICO AT CAYEY   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG RESEARCH; DRUG UTILIZATION; EPIDEMIC; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; NONPROPORTIONAL MODEL; PREDICTION; PROPORTIONAL MODEL; STATISTICAL MODEL; CIVIL DEFENSE; DRUG STORAGE; HEALTH SERVICE; HUMAN; METHODOLOGY; THEORETICAL MODEL; VACCINATION;

CIVIL DEFENSE; DISEASE OUTBREAKS; DRUG STORAGE; HEALTH SERVICES ADMINISTRATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, THEORETICAL; VACCINATION;

EID: 79960848938     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-207     Document Type: Article

References (89)

1. Chowell G, Miller M, Viboud C. Seasonal influenza in the United States, France, and Australia: Transmission and prospects for control. Epidemiology and infection 2008, 136(06):852-864. 2680121,2680121, 17634159.
2. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus ADME, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RAM, Smith DJ. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008, 320(5874):340-346. 10.1126/science.1154137, 18420927.
3. Simonsen L, Clarke M, Schonberger L, Arden N, Cox N, Fukuda K. Pandemic versus epidemic influenza mortality: A pattern of changing age distribution. The Journal of Infectious Diseases 1998, 178:53-60.
4. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine. Supplement 1999, 17:S3-S10.
5. Stohr K. Influenza-WHO cares. The Lancet Infectious Diseases 2002, 2(9):517.. 10.1016/S1473-3099(02)00366-3, 12206966.
6. Viboud C, Bjornstad O, Smith D, Simonsen L, Miller M, Grenfell B. Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 2006, 312(5772):447.. 10.1126/science.1125237, 16574822.
7. Osterholm M. Preparing for the next pandemic. New England Journal of Medicine 2005, 352(18):1839-1842. 10.1056/NEJMp058068, 15872196.
8. Stohr K, Esveld M. Will vaccines be available for the next influenza pandemic?. Science 2004, 306(5705):2195-2196. 10.1126/science.1108165, 15618505.
9. World Health Organization WHO guidelines on the use of vaccines and antivirals during influenza pandemics. 2004, World Health Organization., http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_RMD_2004_8/en/
10. World Health Organization Strengthening pandemic influenza preparedness and response. 2005, World Health Organization., http://www.who.int/csr/disease/influenza/A58_13-en.pdf
11. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008, 26:D31-D34.
12. Gross P, Hermogenes A, Sacks H, Lau J, Levandowski R. The efficacy of influenza vaccine in elderly persons. Annals of Internal Medicine 1995, 123(7):518-527.
13. Nichol K. Efficacy and effectiveness of influenza vaccination. Vaccine 2008, 26:D17-D22.
14. Ramet J, Weil-Olivier C, Sedlak W. Influenza vaccination: The paediatric perspective. Vaccine 2007, 25(5):780-787. 10.1016/j.vaccine.2006.09.042, 17101199.
15. Fedson D. Preparing for pandemic vaccination: an international policy agenda for vaccine development. Journal of Public Health Policy 2005, 26:4-29. 10.1057/palgrave.jphp.3200008, 15906873.
16. Glezen W. Herd protection against influenza. Journal of Clinical Virology 2006, 37(4):237-243. 10.1016/j.jcv.2006.08.020, 17008123.
17. Lee V, Fernandez G, Chen M, Lye D, Leo Y. Influenza and the pandemic threat. Singapore Medical Journal 2006, 47(6):463-470.
18. Miller M, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics-implications for policy. New England Journal of Medicine 2009, 360(25):2595-2598. 10.1056/NEJMp0903906, 19423872.
19. World Health Organization Pandemic influenza preparedness and response. 2009, World Health Organization., http://www.who.int/csr/disease/influenza/pipguidance2009/en/index.html
20. Fedson D. Pandemic influenza and the global vaccine supply. Clinical Infectious Diseases 2003, 36(12):1552-1561. 10.1086/375056, 12802755.
21. Macroepidemiology of Influenza Vaccination Study Group The Macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005, 23(44):5133-5143. Macroepidemiology of Influenza Vaccination Study Group.
22. Oshitani H, Kamigaki T, Suzuki A. Major issues and challenges of influenza pandemic preparedness in developing countries. Emerging Infectious Diseases 2008, 14(6):875-880. 10.3201/eid1406.070839, 2600290, 18507896.
23. Kieny MP, Costa A, Hombach J, Carrasco P, Pervikov Y, Salisbury D, Greco M, Gust I, LaForce M, Franco-Paredes C, Santos JI, D'Hondt E, Rimmelzwaan G, Karron R, Fukuda K. A global pandemic influenza vaccine action plan. Vaccine 2006, 24(40-41):6367-6370. 10.1016/j.vaccine.2006.07.021, 17240560.
24. Yamada T. Poverty, wealth, and access to pandemic influenza vaccines. New England Journal of Medicine 2009, 361(12):1129-1131. 10.1056/NEJMp0906972, 19675324.
25. Aaby K, Abbey R, Herrmann J, Treadwell M, Jordan C, Wood K. Embracing computer modeling to address pandemic influenza in the 21st century. Journal of Public Health Management and Practice 2006, 12(4):365-372.
26. Centers For Disease Control and Prevention Large-scale vaccination clinic output and staffing estimates: An example. 2009, Centers For Disease Control and Prevention., http://www.cdc.gov/h1n1flu/vaccination/statelocal/settingupclinics.htm
27. Cho B, Hicks K, Honeycutt A, Hupert N, Khavjou O, Messonnier M, Washington M. A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics. Journal of Public Health Management and Practice 2011, 17:E22-E28.
28. Peterborough County-City Health Unit Pandemic Influenza Plan, Annex A: Mass Vaccination Plan. 2010, Peterborough County-City Health Unit., http://pcchu.peterborough.on.ca/IC/IC-pandemic-plan.html
29. Phillips F, Williamson J. Local health department applies incident management system for successful mass influenza clinics. Journal of Public Health Management and Practice 2005, 11(4):269..
30. Washington M. Evaluating the capability and cost of a mass influenza and pneumococcal vaccination clinic via computer simulation. Medical Decision Making 2009, 29(4):414-423. 10.1177/0272989X09333126, 19564434.
31. Germann T, Kadau K, Longini I, Macken C. Mitigation strategies for pandemic influenza in the United States. PNAS 2006, 103(15):5935-5940. 10.1073/pnas.0601266103, 1458676, 16585506.
32. Longini I, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings D, Halloran M. Containing pandemic influenza at the source. Science 2005, 309(5737):1083-1087. 10.1126/science.1115717, 16079251.
33. Nuňo M, Chowell G, Gumel A. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands. Journal of the Royal Society Interface 2007, 4(14):505-521.
34. Yang Y, Sugimoto J, Halloran M, Basta N, Chao D, Matrajt L, Potter G, Kenah E, Longini I. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009, 326(5953):729.. 10.1126/science.1177373, 2880578, 19745114.
35. Carrat F, Luong J, Lao H, Sallé A, Lajaunie C, Wackernagel H. A'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Medicine 2006, 4:26. 10.1186/1741-7015-4-26, 1626479, 17059593.
36. Chowell G, Viboud C, Wang X, Bertozzi S, Miller M. Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS ONE 2009, 4(12):e8164.. 2781783, 19997603.
37. Ciofi degli Atti M, Merler S, Rizzo C, Ajelli M, Massari M, Manfredi P, Furlanello C, Scalia Tomba G, Iannelli M, Ahmed N. Mitigation measures for pandemic influenza in Italy: An individual based model considering different scenarios. PLoS ONE 2008, 3:e1790. 10.1371/journal.pone.0001790, 2258437, 18335060.
38. Ferguson N, Cummings D, Fraser C, Cajka J, Cooley P, Burke D. Strategies for mitigating an influenza pandemic. Nature 2006, 442(7101):448-452. 10.1038/nature04795, 16642006.
39. Flahault A, Vergu E, Coudeville L, Grais R. Strategies for containing a global influenza pandemic. Vaccine 2006, 24(44-46):6751-6755. 10.1016/j.vaccine.2006.05.079, 16843574.
40. Lee BY, Brown ST, Cooley P, Grefenstette JJ, Zimmerman RK, Zimmer SM, Potter MA, Rosenfeld R, Wheaton WD, Wiringa AE, Bacon KM, Burke DS. Vaccination deep into a pandemic wave: Potential mechanisms for a "third wave" and the impact of vaccination. American Journal of Preventive Medicine 2010, 39(5):e21-e29. 10.1016/j.amepre.2010.07.014, 20965375.
41. Centers For Disease Control and Prevention Influenza symptoms and laboratory diagnostic procedures. (accessed March, 2011), Centers For Disease Control and Prevention., http://www.cdc.gov/flu/professionals/diagnosis/labprocedures.htm
42. Prosper O, Saucedo O, Thompson D, Torres-Garcia G, Wang X, Castillo-Chavez C. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza. Mathematical Biosciences and Engineering (MBE) 2011, 8:141-170.
43. Arino J, Brauer F, Van Den Driessche P, Watmough J, Wu J. A model for influenza with vaccination and antiviral treatment. Journal of Theoretical Biology 2008, 253:118-130. 10.1016/j.jtbi.2008.02.026, 18402981.
44. Epstein J, Goedecke D, Yu F, Morris R, Wagener D, Bobashev G. Controlling pandemic flu: the value of international air travel restrictions. PLoS One 2007, 2(5):401..
45. Ghosh S, Heffernan J, Galvani A. Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study. PloS ONE 2010, 5(12):e14307.. 3004963, 21187938.
46. Gojovic M, Sander B, Fisman D, Krahn M, Bauch C. Modelling mitigation strategies for pandemic (H1N1) 2009. Canadian Medical Association Journal 2009, 181(10):673-680. 10.1503/cmaj.091641, 2774362, 19825923.
47. Riley S, Wu J, Leung G. Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate. PLoS Med 2007, 4(6):e218.. 1892041, 17579511.
48. Vardavas R, Breban R, Blower S. Can influenza epidemics be prevented by voluntary vaccination?. PLoS Computational Biology 2007, 3(5):e85.. 1864996, 17480117.
49. Bowman C, Arino J, Moghadas S. Evaluation of vaccination strategies during pandemic outbreaks. Mathematical Biosciences and Engineering (MBE) 2011, 8:113-122.
50. Kermack W, McKendrick A. Contributions to the mathematical theory of epidemics. Proceedings of the Royal Society of London 1927, 115:700-721.
51. Coburn B, Wagner B, Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu(H 1 N 1). BMC Medicine 2009, 7:30. 10.1186/1741-7015-7-30, 2715422, 19545404.
52. Acuňa-Soto R, Castaňeda-Davila L, Chowell G. A perspective on the 2009 A/H1N1 influenza pandemic in Mexico. Mathematical Biosciences and Engineering (MBE) 2011, 8:223-238.
53. del Rio C, Guarner J. The 2009 influenza A (H1N1) pandemic: What have we learned in the past 6 months. Transactions of the American Clinical and Climatological Association 2010, 121:128-140. 2917128, 20697556.
54. Leung G, Nicoll A. Reflections on Pandemic (H1N1) 2009 and the International Response. PLoS Med 2010, 7(10):e1000346.. 2950129, 20957189.
55. Carrat F, Vergu E, Ferguson N, Lemaitre M, Cauchemez S, Leach S, Valleron A. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. American Journal of Epidemiology 2008, 167(7):775-785. 10.1093/aje/kwm375, 18230677.
56. Couch R, Douglas R, Fedson D, Kasel J. Correlated studies of a recombinant influenza-virus vaccine. III. Protection against experimental influenza in man. The Journal of Infectious Diseases 1971, 124(5):473-480. 10.1093/infdis/124.5.473, 5000515.
57. Foy H, Cooney M, Allan I, Albrecht J. Influenza B in households: virus shedding without symptoms or antibody response. American Journal of Epidemiology 1987, 126(3):506-515.
58. Couch R, Kasel J. Immunity to influenza in man. Annual Reviews in Microbiology 1983, 37:529-549.
59. Hayden F, Fritz R, Lobo M, Alvord W, Strober W, Straus S. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. Journal of Clinical Investigation 1998, 101(3):643-649. 10.1172/JCI1355, 508608, 9449698.
60. Health Industry Distributors Association 2008-2009 influenza vaccine production and distribution. 2009, Health Industry Distributors Association., http://www.flusupplynews.com/documents/09_FluBrief.pdf
61. Oliver Wyman Group and Program for Appropriate Technology in Health Influenza vaccine strategies for broad global access, key findings and project methodology. 2007, Oliver Wyman Group and Program for Appropriate Technology in Health., http://www.path.org/files/VAC_infl_publ_rpt_10-07.pdf
62. Herrera-Valdez M, Cruz-Aponte M, Castillo-Chavez C. Multiple outbreaks for the same pandemic: Local transportation and social distancing explain the different" waves" of A-H1N1pdm cases observed in México during 2009. Mathematical Biosciences and Engineering (MBE) 2011, 8:21-48.
63. Izhikevich E. Dynamical systems in neuroscience: The geometry of excitability and bursting 2007, The MIT press.
64. Herrera-Valdez M. Derivation and analysis of biophysical core models of membrane excitability: From cellular to network dynamics. PhD thesis 2008, University of Arizona.
65. Atkinson K, Han W. Elementary numerical analysis 1993, Wiley New York.
66. Jones E, Oliphant T, Peterson P. SciPy: Open source scientific tools for Python. 2001, http://www.scipy.org/
67. Hunter J, Dale D, Droettboom M. Matplotlib: A Python 2D plotting library. 2008, http://matplotlib.sourceforge.net/
68. World Health Organization Global pandemic influenza action plan to increase vaccine supply: Progress report 2008. 2008, World Health Organization., http://www.who.int/vaccine_research/Global_Pandemic_Influenza.pdf
69. Wikipedia List of countries by population. (accessed March, 2011), Wikipedia., http://en.wikipedia.org/wiki/List_of_countries_by_population
70. US Census Bureau International data base (IDB). (accessed March, 2011), US Census Bureau., http://www.census.gov/ipc/www/idb/
71. Abelin A, Colegate T, Gardner S, Hehme N, Palache A. Lessons from pandemic influenza A (H1N1): The research-based vaccine industry's perspective. Vaccine 2011, 1135-1138.
72. Partridge J, Kieny MP. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 2010, 28(30):4709-4712. 10.1016/j.vaccine.2010.04.083, 20488262.
73. Low D, McGeer A. Pandemic (H1N1) 2009: assessing the response. Canadian Medical Association Journal 2010, 182:17. 10.1503/cmaj.109-3104, 2802600, 19917665.
74. Rambhia K, Watson M, Sell T, Waldhorn R, Toner E. Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 2010, 259-263.
75. Public Health Agency of Canada Weekly distribution of the H1N1 flu vaccine. (accessed March, 2011), Public Health Agency of Canada., http://www.phac-aspc.gc.ca/alert-alerte/h1n1/vacc/vacc-archive/dist-archive-eng.php
76. Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, Pelletier L. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. Canadian Medical Association Journal 2010, 182(18):1981.. 10.1503/cmaj.100746, 3001504, 21059773.
77. Sander B, Bauch CT, Fisman D, Fowler RA, Kwong JC, Maetzel A, McGeer A, Raboud J, Scales DC, Gojovic MZ, Krahn M. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience. Vaccine 2010, 6210-6220.
78. Fernández ML. A/H1N1 Epidemic in México: Lessons Learned. Talk at Mitigating the Spread of A/H1N1 Flu: Lessons Learned from Past Outbreaks Workshop. Arizona State University 2009,
79. Vargas-Parada L. H1N1: A Mexican Perspective. Cell 2009, 139(7):1203-1205. 10.1016/j.cell.2009.12.019, 20064360.
80. World Health Organization Global pandemic influenza action plan to increase vaccine supply. 2006, World Health Organization., http://www.who.int/vaccines-documents/DocsPDF06/863.pdf
81. Hartvigsen G, Dresch J, Zielinski A, Macula A, Leary C. Network structure, and vaccination strategy and effort interact to affect the dynamics of influenza epidemics. Journal of Theoretical Biology 2007, 246(2):205-213. 10.1016/j.jtbi.2006.12.027, 17303174.
82. World Health Organization Informal consultation on influenza pandemic preparedness in countries with limited resources. 2004, World Health Organization., http://www.who.int/entity/csr/resources/publications/influenza/CDS_CSR_GIP_2004_1.pdf
83. Centers For Disease Control and Prevention Vaccine against 2009 H1N1 influenza virus. (accessed March, 2011), Centers For Disease Control and Prevention., http://www.flu.gov/individualfamily/vaccination/h1n1vaccine_qa_public.html
84. Flahault A, De Lamballerie X, Hanslik T, Salez N. Symptomatic infections less frequent with H1N1pdm than with seasonal strains. PLoS Currents 2009, 1.
85. Bauer A, Beauchemin C, Perelson A. Agent-based modeling of host-pathogen systems: the successes and challenges. Information Sciences 2009, 179(10):1379-1389. 10.1016/j.ins.2008.11.012, 2731970, 20161146.
86. Monto A, Koopman J, Longini I. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. American Journal of Epidemiology 1985, 121(6):811-822.
87. Viboud C, Tam T, Fleming D, Handel A, Miller M, Simonsen L. Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 2006, 24(44-46):6701-6707. 10.1016/j.vaccine.2006.05.067, 16806596.
88. Thompson W, Shay D, Weintraub E, Brammer L, Cox N, Anderson L, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA: the journal of the American Medical Association 2003, 289(2):179..
89. Heffernan J, Smith R, Wahl L. Perspectives on the basic reproductive ratio. Journal of the Royal Society Interface 2005, 2(4):281..